|
|
|
|
|
|
|
|
Ovarian Cancer National Alliance
Take Action and let Congress know you want safe and reliable test results!
Report language nestled in a
House Appropriations bill up for vote in committee this week would
delay the Food and Drug Administration (FDA) from finalizing guidance to
regulate laboratory developed tests (LDTs). The FDA's proposed guidance
would ensure that LDTs are safe, accurate and reliable. A laboratory
developed test is anything from a BRCA genetic test, to a CA-125 blood
test. Click here to take action now.
Why is it important to have the FDA regulate LDTs?
Why is it important to have the FDA regulate LDTs?
These tests are
increasingly used to guide complex medical treatment decisions. The
consequences of inaccurate test results, such as false positives, can
result in the unnecessary removal of a woman's ovaries. It is critical
that patients know their test results can be trusted.....
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.